BioSpace News Archive

Biotech Beach

BiVACOR Names Veteran Medical Device Executive Jim Dillon as Chief Executive Officer

BiVACOR, Inc., a clinical-stage medical technology company developing a total artificial heart, announced that Jim Dillon has been named chief executive officer and a member of its board of directors.

January 3, 2024
·
3 min read
BioCapital

Molecular Diagnostics Research That Could Transform Healthcare Featured in the January Issue of ADLM’s The Journal of Applied Laboratory Medicine

Molecular diagnostics is a powerful branch of laboratory medicine that examines the fundamental genetic and biochemical components of life to provide invaluable insights into health and disease.

January 3, 2024
·
4 min read
Drug Development

ChemDiv Marks a Milestone as Orionis Biosciences’ Novel Immunotherapy Enters Phase I Clinical Trials

ChemDiv Inc, a leading provider of drug discovery platforms and development solutions, celebrates a significant milestone in collaboration with Orionis Biosciences: the commencement of Phase I clinical trials for ORB-011, a cutting-edge attenuated, cis-targeted interferon immunotherapy compound.

January 3, 2024
·
1 min read
Pharm Country

Starton Therapeutics Announces Initial Key Safety and Efficacy Signals with STAR-LLD in Patients with Relapsed or Refractory Multiple Myeloma

Starton Therapeutics Inc. announced initial key safety and efficacy signals of its STAR-LLD Phase 1b clinical trial in multiple myeloma.

January 3, 2024
·
4 min read
Business

Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncology

Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it has entered into a strategic collaboration and licensing agreement with BridGene Biosciences, Inc. (“Bridgene”), a biotechnology company that uses proprietary chemoproteomics technology to discover novel small molecule drug candidates.

January 3, 2024
·
5 min read
Bio NC

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 03, 2024

BioCryst Pharmaceuticals, Inc. announced that the compensation committee of BioCryst’s board of directors granted eight newly-hired employees stock options to purchase an aggregate of 48,700 shares, and restricted stock units covering an aggregate of 34,000 shares, of BioCryst common stock.

January 3, 2024
·
1 min read
Business

ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024

ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2024 on Wednesday, January 24, 2024, after the New York Stock Exchange closes.

January 3, 2024
·
1 min read
Business

Foghorn Therapeutics Announces CFO Departure - Jan 03, 2024

Foghorn® Therapeutics Inc. announced that Chief Financial Officer, Allan Reine will be departing the Company to pursue another opportunity.

January 3, 2024
·
2 min read
BioMidwest

Merit Medical to Present at the J.P. Morgan 42nd Annual Healthcare Conference

Merit Medical Systems, Inc. announced that Merit Chairman and CEO, Fred Lampropoulos, is scheduled to present at the J.P. Morgan 42nd Annual Healthcare Conference on January 8, 2024, at 4:30pm PT.

January 3, 2024
·
1 min read
CONMED Corporation to Announce Fourth Quarter 2023 Financial Results on January 31, 2024

CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the fourth quarter 2023 after the market close on Wednesday, January 31, 2024.

January 3, 2024
·
2 min read